MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income
$150,049K
Amortization of intangible
assets
$29,512K
Inventories
-$27,379K
Share-based compensation
$16,637K
Depreciation and
amortization
$4,221K
Deferred income taxes
-$3,428K
Amortization of debt discount
$2,245K
Lease payments
recognized
-$214K
Net cash provided by
operating activities
$180,078K
Canceled cashflow
$53,607K
Net increase in cash
and cash...
$175,588K
Canceled cashflow
$4,490K
Accounts payable and
accrued expenses
-$24,922K
Accounts receivable, net
and contract assets
$19,547K
Prepaid expenses and
other assets
$9,108K
Accretion of premium on
marketable securities, net
$30K
something is missing
$448,873K
Proceeds from working
capital adjustments on...
$710K
Net cash used in
investing activities
-$2,877K
Net cash used in
financing activities
-$1,613K
Canceled cashflow
$449,583K
Proceeds from sales and
maturities of marketable...
-$439,873K
Taxes paid related to
net share...
$1,613K
Purchases of marketable
securities
$8,846K
Purchases of property and
equipment
$3,741K
Back
Back
Cash Flow
HALOZYME THERAPEUTICS, INC. (HALO)
HALOZYME THERAPEUTICS, INC. (HALO)
source: myfinsight.com